Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.
NEW YORK--(BUSINESS WIRE)--Pagaya Technologies LTD. (NASDAQ: PGY) (Pagaya or “the Company”), a global technology company delivering AI-driven product solutions for the financial ecosystem, today an...
SEATTLE--(BUSINESS WIRE)--(NASDAQ: RDFN) — Over half of U.S. homeowners and renters (51.2%) strongly or somewhat agree with the following statement: “Less immigration will result in fewer construct...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and comme...
MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced that the company will present intranasal human abusability data fro...
NEW YORK--(BUSINESS WIRE)--IMAX Corporation (NYSE: IMAX) today announced an increase of $100 million in the Company’s share repurchase program along with a one-year extension through June 30, 2027....
NEW YORK--(BUSINESS WIRE)--Pagaya Technologies LTD. (NASDAQ: PGY) (Pagaya or “the Company”), a global technology company delivering AI-driven product solutions for the financial ecosystem, today an...
SEATTLE--(BUSINESS WIRE)--(NASDAQ: RDFN) — Over half of U.S. homeowners and renters (51.2%) strongly or somewhat agree with the following statement: “Less immigration will result in fewer construct...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and comme...
MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced that the company will present intranasal human abusability data fro...
NEW YORK--(BUSINESS WIRE)--IMAX Corporation (NYSE: IMAX) today announced an increase of $100 million in the Company’s share repurchase program along with a one-year extension through June 30, 2027....